MEK inhibitor

You have access
The Combination of Trametinib, a MEK Inhibitor, and Temsirolimus, an mTOR Inhibitor, Radiosensitizes Lung Cancer Cells
SEO YUN KIM, EUN-HUI JEONG, TAE-GUL LEE, HYE-RYOUN KIM and CHEOL HYEON KIM

Anticancer Research June 2021, 41 (6) 2885-2894; DOI: https://doi.org/10.21873/anticanres.15070
You have access
Selumetinib Inhibits Melanoma Metastasis to Mouse Liver via Suppression of EMT-targeted Genes
SEUNG-HEE RYU, SEUNG-HO HEO, EUN YOUNG PARK, KYUNG-CHUL CHOI, JE-WON RYU, SEOK HO LEE and SANG-WOOK LEE

Anticancer Research February 2017, 37 (2) 607-614;
You have access
MEK Inhibitor Suppresses Expression of the miR-17-92 Cluster with G₁-Phase Arrest in HT-29 Human Colon Cancer Cells and MIA PaCa-2 Pancreatic Cancer Cells
RYOICHI TANAKA, MITSUHIRO TOMOSUGI, TOSHIYUKI SAKAI and YOSHIHIRO SOWA

Anticancer Research September 2016, 36 (9) 4537-4543;

Main menu